The focus on precise medicine enhances the need for timely diagnosis and frequent
monitoring of chronic diseases. Moreover, the recent pandemic of severe acute respiratory …

Recent years have shown that the diagnosis and monitoring of biomarkers involved in
inflammatory-associated medical conditions such as cancer, neurological disorders, viral …

The disastrous spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has induced severe public healthcare issues and weakened the global economy …

The COVID-19 pandemic has led to a global crisis with devastating effects on public
healthcare and the economy. Sensitive detection of SARS-CoV-2 is the key to diagnose and …

The CRISPR/Cas systems have provided wide biosensing applications. Particularly, the
aptamer-involved CRISPR/Cas sensor system powerfully expanded to non-nucleic-acid …

Herein, we have proposed a straightforward and label-free electrochemical immunosensing
strategy supported on a glassy carbon electrode (GCE) modified with a biocompatible and …

Introduction Symptomatic testing and asymptomatic screening for SARS-CoV-2 continue to
be essential tools for mitigating virus transmission. Though COVID-19 diagnostics initially …

In recent years, electrochemical biosensors (ECBSs) have shown significant potential for
real-time disease diagnosis and in situ physical condition monitoring. As a multi-constituent …

Circulating microRNAs (miRNAs) can be regarded as reliable noninvasive biomarkers in
body fluids for the early diagnosis, prognosis, and monitoring of cancers. By combining …

COVID-19, a viral respiratory illness, is caused by Severe Acute Respiratory Syndrome
Corona Virus 2 (SARS-CoV-2), which was first identified in Wuhan, China, in 2019 and …